John Joseph Feeney is SVP & Chief Medical Officer at Vanda Pharmaceuticals Inc. (VNDA). They have made 6 open-market trades across 1 company since 2009, most recently 2012-02-16.
CIK 0001454240
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 6 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| VNDA | 14,927 | $60K |
Shares reported on the most recent Form 4, priced at the 2012-02-21 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| VNDA | SELL | 2012-02-16 | 2012-02-21 | $4.65 | $22K | -4.3% | -1.1% | -1.1% |
| VNDA | SELL | 2010-02-19 | 2010-02-23 | $10.56 | $211K | -4.3% | -1.1% | -1.1% |
| VNDA | SELL | 2009-11-06 | 2009-11-10 | $10.33 | $147K | -4.3% | -1.1% | -1.1% |
| VNDA | SELL | 2009-05-18 | 2009-05-18 | $12.00 | $79K | -4.3% | -1.1% | -1.1% |
| VNDA | SELL | 2009-05-13 | 2009-05-14 | $12.21 | $37K | -4.3% | -1.1% | -1.1% |
| VNDA | SELL | 2009-05-11 | 2009-05-13 | $10.16 | $157K | -4.3% | -1.1% | -1.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.